{
  "url": "https://openlegislation.uk/medicines-products-for-human-use-fees-amendment-regulations-2025/introduction",
  "json_url": "https://openlegislation.uk/medicines-products-for-human-use-fees-amendment-regulations-2025/introduction.json",
  "legislation": "uksi/2025/317",
  "legislation_title": "The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025",
  "legislation_url": "https://openlegislation.uk/medicines-products-for-human-use-fees-amendment-regulations-2025",
  "path": "introduction",
  "kind": "introduction",
  "number": null,
  "heading": "Introductory text",
  "text": "MEDICINES\nFEES AND CHARGES\nMade at 10.02 a.m. on 11th March 2025\nLaid before Parliament at 4.00 p.m. on 11th March 2025\nLaid before the Northern Ireland Assembly at 4.00 p.m. on 11th March 2025\nComing into force 1st April 2025\nThe Secretary of State in relation to England and Wales and Scotland, and the Department of Health in Northern Ireland and the Secretary of State acting jointly in relation to Northern Ireland, make these Regulations in exercise of the powers conferred by section 2(1), 6(1)(a) and 43(2) of the Medicines and Medical Devices Act 2021.\nThe Secretary of State and the Department of Health in Northern Ireland have carried out a public consultation in accordance with section 45(1) of that Act.\nIn accordance with section 2(2) to (4) of that Act, the Secretary of State’s and the Department of Health in Northern Ireland’s overarching objective in making these Regulations is safeguarding public health, and the Secretary of State and the Department of Health in Northern Ireland have had regard to the matters specified in section 2(3) of that Act and consider that, where these Regulations may have an impact on the safety of human medicines, the benefits of making these Regulations outweigh the risks.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "2021 c. 3. The powers in section 2(1) of the Medicines and Medical Devices Act 2021, and in the provisions that relate to it, are exerciseable by the “appropriate authority”. See section 2(6) of that Act, which contains the definition of “appropriate authority” that is relevant to the powers being exercised. See section 9 of that Act for the definition of “law relating to human medicines” for the purposes of section 2(1) of that Act, and section 6(4) of that Act for the definition of “human medicines provision” for the purposes of section 6(1)(a) of that Act."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2025/317/introduction",
    "retrieved_at": "2026-10-28T21:18:55.696056+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}